focus on infants particularly likely to develop ROP. However, any study of the effects of ␤-blocker therapy must address the fragility of the patients to be tested and possible systemic and ocular adverse effects. Nevertheless, if topical ␤-blockers prove to be effective in preventing some cases of ROP, this opens the door for a more individualized approach to prevention of the disease, eg, using ␤-adrenergic receptor polymorphisms to guide ROP management.
. B-scan ultrasonography revealed anterior vitreous bands, tractional retinal detachment (TRD), and a small choroidal detachment ( Figure 1B) . Review of B-scan ultrasonographic images performed 2 months previously, before KPro placement, showed a normal posterior segment. A 23-gauge pars plana vitrectomy was performed to repair the TRD. Pars plana vitrectomy revealed a dense anterior vitreous band contiguous with a TRD and epiretinal membrane (ERM) extending across the macula. Extensive membrane peeling was performed, followed by fluid-air exchange, endolaser, and silicone oil injection. A large ERM specimen from the macula was sent for histopathologic evaluation. Microscopic evaluation of the ERM revealed mucosal epithelium containing goblet cells on hematoxylin-eosin, periodic acid-Schiff base, and MassonTrichrome staining, consistent with ED (Figure 2) . Immunohistochemical analysis with cytokeratin showed positive staining, revealing epithelial cells lining one side of the ERM (Figure 2) . At the patient's 2-month followup, slitlamp examination revealed recurrent intraprosthetic membrane and flat retina by indirect ophthalmoscopy and optical coherence tomography.
Comment. Epithelial downgrowth of the posterior segment is rare but can manifest within months after eye surgery. McDonnell et al 2 reported ED occurring 3 months after ruptured globe repair, lensectomy, and pars plana vitrectomy, wherein TRD and ERM were found to consist of nonkeratinized, stratified squamous epithelium. Our case demonstrates a similar rapid progression of ED into the posterior segment after surgery. B-scan ultrasonography documented a normal-appearing posterior segment before KPro placement. Two months after KPro placement, B-scan ultrasonography showed the large TRD due to ED.
Epithelial downgrowth after KPro placement has been a subject of historical interest. Girard 3 observed that ED only occurred in early KPro models previous to 1972. The Boston KPro was approved by the US Food and Drug Administration in 1992 and has demonstrated ED in only 2 cases. Both cases had ED localized to the anterior chamber due to full-thickness tissue melting at the KProcornea junction from ocular cicatricial pemphigoid. 4 To our knowledge, there have been no published reports of ED after Boston KPro placement involving the posterior segment. In our case, histologic review confirmed that ED of the posterior segment occurred after KPro placement.
Histopathologic findings of ED typically consist of nonkeratinized, stratified squamous or conjunctival epithelium extending over the posterior cornea or anterior sur- face of the iris from an anterior wound site. In phakic or pseudophakic eyes, the posterior lens capsule serves as a barrier preventing further advancement of the epithelium into deeper structures of the eye. Epithelial downgrowth of the posterior segment can occur when this barrier has been disrupted (aphakia, lens luxation or subluxation, iridodialysis) or bypassed (trauma, scleral buckle intrusion).
